| # | Drug | Count |
|---|---|---|
| 0 | WARFARIN | 75 |
| 1 | APIXABAN | 33 |
| 2 | WARFARIN SODIUM | 20 |
| 3 | ASPIRIN | 19 |
| 4 | ASPIRIN 325 MG | 19 |
| 5 | ASPIRIN 81 MG | 19 |
| 6 | DABIGATRAN ETEXILATE MESYLATE | 18 |
| 7 | RIVAROXABAN | 17 |
| 8 | DABIGATRAN ETEXILATE | 12 |
| 9 | FUROSEMIDE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFADROXIL | 4 | 0.0020 |
| 1 | HEPARIN SODIUM AND DEXTROSE | 1 | 0.0014 |
| 2 | EDOXABAN TOSYLATE | 9 | 0.0013 |
| 3 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 6 | 0.0007 |
| 5 | WARFARIN | 75 | 0.0006 |
| 6 | APIXABAN | 33 | 0.0005 |
| 7 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 8 | LEMBOREXANT | 1 | 0.0003 |
| 9 | DABIGATRAN ETEXILATE MESYLATE | 18 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 48 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 2 | Glycopeptide Antibacterial [EPC] | 6 | 0.0001 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 5 | alpha-Adrenergic Blocker [EPC] | 8 | 0.0001 |
| 6 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 15 | 0.0000 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 19 | 0.0000 |